Literature DB >> 29475214

Micro-environment and intracellular metabolism modulation of adipose tissue macrophage polarization in relation to chronic inflammatory diseases.

Xiao Zhu1,2, Yixuan Tu1, Hainan Chen1,2, Ampadu O Jackson1, Vaibhav Patel3, Kai Yin1,2.   

Abstract

The accumulation and pro-inflammatory polarization of immune cells, mainly macrophages, in adipose tissue (AT) are considered crucial factors for obesity-induced chronic inflammatory diseases. In this review, we highlighted the role of adipose tissue macrophage (ATM) polarization on AT function in the obese state and the effect of the micro-environment and intracellular metabolism on the dynamic switch of ATMs into their pro-inflammatory or anti-inflammatory phenotypes, which may have distinct influences on obesity-related chronic inflammatory diseases. Obesity-associated metabolic dysfunctions, including those of glucose, fatty acid, cholesterol, and other nutrient substrates such as vitamin D and iron in AT, promote the pro-inflammatory polarization of ATMs and AT inflammation via regulating the interaction between ATMs and adipocytes and intracellular metabolic pathways, including glycolysis, fatty acid oxidation, and reverse cholesterol transportation. Focusing on the regulation of ATM metabolism will provide a novel target for the treatment of obesity-related chronic inflammatory diseases, including insulin resistance, cardiovascular diseases, and cancers.
Copyright © 2018 John Wiley & Sons, Ltd.

Entities:  

Keywords:  ATMs; inflammation; macrophage polarization; metabolic diseases; obesity

Mesh:

Year:  2018        PMID: 29475214     DOI: 10.1002/dmrr.2993

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  7 in total

Review 1.  Lifestyle Management of Diabetes: Implications for the Bone-Vascular Axis.

Authors:  Silvia Pieralice; Francesca Vigevano; Rossella Del Toro; Nicola Napoli; Ernesto Maddaloni
Journal:  Curr Diab Rep       Date:  2018-08-18       Impact factor: 4.810

2.  Effect of high glucose on cytokine production by human peripheral blood immune cells and type I interferon signaling in monocytes: Implications for the role of hyperglycemia in the diabetes inflammatory process and host defense against infection.

Authors:  Ronghua Hu; Chang-Qing Xia; Edward Butfiloski; Michael Clare-Salzler
Journal:  Clin Immunol       Date:  2018-06-09       Impact factor: 3.969

Review 3.  Insulin Signaling and Insulin Resistance Facilitate Trained Immunity in Macrophages Through Metabolic and Epigenetic Changes.

Authors:  Eleftheria Ieronymaki; Maria G Daskalaki; Konstantina Lyroni; Christos Tsatsanis
Journal:  Front Immunol       Date:  2019-06-12       Impact factor: 7.561

4.  Asaronic Acid Inhibited Glucose-Triggered M2-Phenotype Shift Through Disrupting the Formation of Coordinated Signaling of IL-4Rα-Tyk2-STAT6 and GLUT1-Akt-mTOR-AMPK.

Authors:  Hyeongjoo Oh; Sin-Hye Park; Min-Kyung Kang; Yun-Ho Kim; Eun-Jung Lee; Dong Yeon Kim; Soo-Il Kim; Su Yeon Oh; Woojin Na; Soon Sung Lim; Young-Hee Kang
Journal:  Nutrients       Date:  2020-07-06       Impact factor: 5.717

5.  Editorial: Immune-Modulatory Effects of Vitamin D.

Authors:  Susu M Zughaier; Erik Lubberts; Abdulbari Bener
Journal:  Front Immunol       Date:  2020-09-29       Impact factor: 7.561

6.  Adipocyte-derived lactate is a signalling metabolite that potentiates adipose macrophage inflammation via targeting PHD2.

Authors:  Tianshi Feng; Xuemei Zhao; Ping Gu; Wah Yang; Cunchuan Wang; Qingyu Guo; Qiaoyun Long; Qing Liu; Ying Cheng; Jin Li; Cynthia Kwan Yui Cheung; Donghai Wu; Xinyu Kong; Yong Xu; Dewei Ye; Shuang Hua; Kerry Loomes; Aimin Xu; Xiaoyan Hui
Journal:  Nat Commun       Date:  2022-09-05       Impact factor: 17.694

Review 7.  Obesity-Associated Myeloid Immunosuppressive Cells, Key Players in Cancer Risk and Response to Immunotherapy.

Authors:  Maria Dulfary Sanchez-Pino; Linda Anne Gilmore; Augusto C Ochoa; Justin C Brown
Journal:  Obesity (Silver Spring)       Date:  2021-02-22       Impact factor: 9.298

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.